Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma
Authors:
- 16 May 2008
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 134 (12) , 1363-1369
Abstract
Renal cell carcinoma (RCC) is characterized by a variable and unpredictable clinical course. Thus, accurate prediction of the prognosis is important in clinical settings. We conducted microarray-based study to identify a novel prognostic marker in conventional RCC.Keywords
This publication has 28 references indexed in Scilit:
- Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinomaBritish Journal of Cancer, 2006
- Targeted agents for the treatment of advanced renal cell carcinomaCancer, 2005
- Clear Cell Renal Cell Carcinoma: Gene Expression Analyses Identify a Potential Signature for Tumor AggressivenessClinical Cancer Research, 2005
- USING TUMOR MARKERS TO PREDICT THE SURVIVAL OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMAJournal of Urology, 2005
- Contribution of the Src family of kinases to the appearance of malignant phenotypes in renal cancer cellsMolecular Carcinogenesis, 2005
- A renaissance for SRCNature Reviews Cancer, 2004
- Prognostic Factors of Renal Cell CarcinomaJournal of Urology, 2003
- Post-analysis follow-up and validation of microarray experimentsNature Genetics, 2002
- A Novel Allelic Variant of the Human TSG-6 Gene Encoding an Amino Acid Difference in the CUB ModuleJournal of Biological Chemistry, 2002
- SYSTEMIC THERAPY FOR RENAL CELL CARCINOMAJournal of Urology, 2000